Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine crossover study in adults with transposition of the great arteries after atrial switch repair
ACTRN12621000196842Phase 3Completed
- Sponsor
- Melbourne Health
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ivabradine in transposition of the great arteries (TGA) and Cardiovascular Malformation (CVM) (2 arms), sponsored by Melbourne Health. Primary endpoint: Exercise capacity. Started May 2021; status: completed.
02
Drugs
ivabradine
03
Conditions
transposition of the great arteries (TGA)Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ACTRN12621000196842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000196842.